Clinical Trial Update: Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT [Phase 4]

View source ↗

Summary

Phase 4 trial comparing eplerenone to atenolol for reversing arterial remodeling in adults with hypertension. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atenolol (Atenolol)
• eplerenone (eplerenone)

Snippet

Sponsor: Pfizer | Conditions: Hypertension | Phase 4 | Status: COMPLETED